P H A R M ATA L E N T
MOVERS & SHAKERS
VASANT NARASIMHAN
Vasant Narasimhan, M.D., will become CEO of Novartis, effective February 2018. Dr Narasimhan has held numerous leadership positions across Novartis in commercial, drug development and strategy roles, including Head of Development for Novartis Pharmaceuticals.
ALAN SUMNER
After seven years at Boehringer Ingelheim, Roche Diagnostics has appointed Alan Sumner as Head of Public Affairs. Alan said: “Diagnostics is set to play an increasingly important role in healthcare as more personalised treatments become available, and I am really looking forward to being part of the Roche Diagnostics team at this exciting time.”
Pf GR ADUATE OF THE MONTH Here we feature an outstanding newcomer who is making their mark on the industry. NAME: Nahida Choudhury COMPANY: Roche ROLE: Market Access Associate DEGREE: Bsc Biomedical Science (with a year in industry), University of Surrey NAHIDA SAYS: “It’s great to be the first person to take part in the graduate Market Access rotational programme. Roche offered me an exciting opportunity to work within the diverse teams in market access covering pre and postmarketing authorisation initiatives. I have just completed my first rotation in Market Access Excellence, who provide the foundation for better patient access to medicines and oversee cross-functional processes. This has given me the opportunity to work with many key stakeholders across the business and portfolio. I am looking forward to working with the other teams and enhancing my knowledge.”
BERTRAND BODSON
Bertrand Bodson, Chief Digital and Marketing Officer for Sainsbury’s Argos, has been appointed to the new role of Chief Digital Officer at Novartis. He will start in January 2018 and will be responsible for creating and executing a company-wide digital strategy.
WHO’S GOING WHERE AND WHY THEY’RE GOING THERE. WORDS BY
Rachel Cresswell
3 2 | PH A R M A FI EL D.CO.U K
KNOW A RISING STAR WHO DESERVES A MENTION? RACHEL@PHARMAFIELD.CO.UK